ICH Consults On Harmonized Standards For Choosing Estimands In Clinical Trials
Executive Summary
An addendum to the International Council for Harmonisation's guideline on statistical principles for clinical trials proposes a new framework on how the concept of estimands can be used to help clearly describe the effects of a medicine.
You may also be interested in...
Clear Rules Needed For Disclosing Clinical Trial Estimands
Although estimands are a great tool for clarifying the treatment effects that are being investigated in a clinical trial, existing registries are not well suited for their public disclosure. Industry-wide guidance can help sponsors using different approaches.
Differences Put Aside As ICH Finalizes Guide On Post Approval Changes
An international guideline on managing post approval changes to drugs, which was initially criticized because of its incompatibility with legal frameworks in certain ICH regions such as the EU, has been finalized.
Welcome To The Estimand: Patient-Reported Outcome Framework Gets Warm Response At FDA/ASCO Workshop
Estimand structure is part of effort to generate standard principles and analyses for patient experience data in oncology and beyond.